Juan Jose Marugan, Wenwei Huang, Omid Motabar, Wei Zheng, Jingbo Xiao, Samarjit Patnaik, Noel Southall, Wendy Westbroek, Wendy A Lea, Anton Simeonov, Ehud Goldin, Maria A Debernardi, Ellen Sidransky
Small molecule chaperones are a promising therapeutic approach for the Lysosomal Storage Disorders (LSDs). Here, we report the discovery of a new series of non-iminosugar glucocerebrosidase inhibitors with chaperone capacity, and describe their structure activity relationship (SAR), selectivity, cell activity phamacokinetics.
January 2012: MedChemComm